Időskori makuladegeneráció: vizsgálatok itt: Izrael
9 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- Where
- Jerusalem, Tel Aviv
- Életkor
- 55 év to 64 év
- People
- 110 worldwide
- Run by
- Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00 - 3. fázisTaking peopleStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Where
- Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Rehovot, Tel Aviv, Tsrifin
- Életkor
- 50 év and over
- People
- 561 worldwide
- Run by
- AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00 - 3. fázisTaking peopleExtension Study for the Port Delivery System With Ranibizumab (Portal)
- Where
- Haifa, Jerusalem, Kfar Saba, Petah Tikva, Rehovot, Tel Aviv
- Életkor
- 50 év and over
- People
- 1000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00 - 3. fázisFut, nem toborozSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Where
- Haifa, Holon, Jerusalem, Ramat Gan, Rehovot, Tel Aviv
- Életkor
- 50 év and over
- People
- 480 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07064759 - 2. fázisTaking peopleA Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Where
- Jerusalem, Tel Aviv
- Életkor
- 50 év and over
- People
- 60 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT05626114 - 2/3. fázisTaking peopleA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Where
- Ashkelon, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Rehovot, Tsrifin
- Életkor
- 50 év and over
- People
- 960 worldwide
- Run by
- EyeBiotech Ltd.
See details and how to joinNCT07440225 - 1/2. fázisTaking peopleA Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Tel Aviv
- Életkor
- 55 év to 80 év
- People
- 62 worldwide
- Run by
- Kriya Therapeutics, Inc.
See details and how to joinNCT06765980 - No phaseCsak meghívásosLong-Term Follow Up of VOY-101 Non-nAMD Extension Study
- Where
- Tel Aviv
- Életkor
- 50 év and over
- People
- 88 worldwide
- Run by
- Perceive Biotherapeutics, Inc.
See details and how to joinNCT07660640 - No phaseTaking peopleDevelopment of IPS from Donated Somatic Cells of Patients with Neurological Diseases
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 120
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00874783